MIVOCELL
Live / Allowed — Third extension granted (statement of use) (as of 31 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98734979
- Mark type
- Word mark
- Filed
- 05 Sept 2024
- Published for opposition
- 18 Feb 2025
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of autoimmune diseases and cancer; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of oncological and immune system related diseases and disorders
Owner
- Kyverna Therapeutics, Inc., Emeryville, CA, US
- Kyverna Therapeutics, Inc., Emeryville, CA, US
Prosecution history
- 01 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Aug 2026 — SOU EXTENSION 3 GRANTED
- 31 Aug 2026 — SOU EXTENSION 3 FILED
- 31 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 2 GRANTED
- 24 Feb 2026 — SOU EXTENSION 2 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 1 GRANTED
- 10 Sept 2025 — SOU EXTENSION 1 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED